Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
Meta Platforms (Facebook)
META
|
+$742M |
| 3 |
Wells Fargo
WFC
|
+$363M |
| 4 |
Salesforce
CRM
|
+$310M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$869M |
| 2 |
Apple
AAPL
|
+$693M |
| 3 |
PPLI
People Inc
PPLI
|
+$488M |
| 4 |
Expedia Group
EXPE
|
+$409M |
| 5 |
Charter Communications
CHTR
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.96% |
| 2 | Healthcare | 2.64% |
| 3 | Financials | 2.22% |
| 4 | Consumer Discretionary | 2.1% |
| 5 | Industrials | 1.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5801
SoundThinking
SSTI
$107M
| $1.05M | ﹤0.01% |
33,801
+15,796
| +88% | +$434K |
|
5802
Akebia Therapeutics
AKBA
$241M
| $1.05M | ﹤0.01% |
417,129
+368,387
| +756% | +$3.23M |
|
|
HONE
5803
DELISTED
HarborOne Bancorp
HONE
| $1.05M | ﹤0.01% |
129,647
+72,914
| +129% | +$623K |
|
5804
CALL
iPath Series B S&P 500 VIX Mid-Term Futures ETN
VXZ
$30.5M
| $1.05M | ﹤0.01% |
7,700
+250
| +3% | +$33.3K |
|
5805
Abeona Therapeutics
ABEO
$361M
| $1.04M | ﹤0.01% |
40,994
-17,466
| -30% | -$1.1M |
|
5806
LeMaitre Vascular
LMAT
$1.87B
| $1.04M | ﹤0.01% |
32,117
+10,984
| +52% | +$330K |
|
5807
Resources Connection
RGP
$145M
| $1.04M | ﹤0.01% |
90,476
-18,520
| -17% | -$220K |
|
5808
PUT
Worthington Enterprises
WOR
$2.85B
| $1.04M | ﹤0.01% |
41,523
+6,650
| +19% | +$162K |
|
5809
PUT
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$168M
| $1.04M | ﹤0.01% |
18,100
-24,500
| -58% | -$1.42M |
|
5810
Krystal Biotech
KRYS
$9.72B
| $1.04M | ﹤0.01% |
24,224
+2,595
| +12% | +$113K |
|
5811
Fidelity International High Dividend ETF
FIDI
$363M
| $1.04M | ﹤0.01% |
65,814
+19,020
| +41% | +$313K |
|
5812
Cambria Global Value ETF
GVAL
$600M
| $1.04M | ﹤0.01% |
+60,420
| New | +$1.09M |
|
|
SVM
5813
Silvercorp Metals
SVM
$2.61B
| $1.04M | ﹤0.01% |
144,123
+89,303
| +163% | +$659K |
|
5814
iShares Core Dividend ETF
DIVB
$1.8B
| $1.04M | ﹤0.01% |
36,262
+26,967
| +290% | +$773K |
|
5815
CALL
Royalty Pharma
RPRX
$26.1B
| $1.04M | ﹤0.01% |
24,700
+6,400
| +35% | +$275K |
|
|
MDLA
5816
PUT
DELISTED
Medallia, Inc.
MDLA
| $1.04M | ﹤0.01% |
37,900
-37,800
| -50% | -$1.15M |
|
5817
BancFirst
BANF
$3.89B
| $1.04M | ﹤0.01% |
25,409
-33,676
| -57% | -$1.42M |
|
5818
CALL
PTC Therapeutics
PTCT
$6.01B
| $1.04M | ﹤0.01% |
22,200
-10,200
| -31% | -$502K |
|
|
ALTR
5819
DELISTED
Altair Engineering Inc
ALTR
| $1.04M | ﹤0.01% |
24,699
-11,766
| -32% | -$473K |
|
|
WPS
5820
DELISTED
iShares International Developed Property ETF
WPS
| $1.04M | ﹤0.01% |
32,961
-20,072
| -38% | -$631K |
|
5821
Cytosorbents Corp
CTSO
$22.8M
| $1.03M | ﹤0.01% |
129,803
+34,164
| +36% | +$308K |
|
5822
PUT
LPL Financial
LPLA
$29.5B
| $1.03M | ﹤0.01% |
13,500
-36,700
| -73% | -$2.91M |
|
5823
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.13B
| $1.03M | ﹤0.01% |
13,610
-15,470
| -53% | -$1.19M |
|
|
PAND
5824
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
| $1.03M | ﹤0.01% |
+90,316
| New | +$1.54M |
|
|
PARAA
5825
DELISTED
Paramount Global Class A
PARAA
| $1.03M | ﹤0.01% |
34,140
+4,883
| +17% | +$143K |
|
Similar funds
Citadel Advisors's Q3 2020 Portfolio in Review
As of Q3 2020, Citadel Advisors held 11,253 positions worth $353B, up 26% from $280B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Citadel Advisors deployed $24.6B of net new capital in Q3 2020, opening 1,597 new positions and adding to 4,071 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 4,016,602 shares worth $256M.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.3% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Amazon, an estimated $869M trimmed.
- Citadel Advisors's largest Q3 2020 buy was iShares MSCI EAFE ETF: 4,016,602 shares worth $256M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $1.04B increase.
- Citadel Advisors's biggest Q3 2020 reduction was Amazon, cutting an estimated $869M.
- Citadel Advisors fully exited Intel in Q3 2020, selling an estimated $249M.
- Citadel Advisors's ten largest holdings make up 36% of its $353B portfolio in Q3 2020.
- Citadel Advisors opened 1,597 new positions and closed 1,264 in Q3 2020.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $353B.
Based on Citadel Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.